365 related articles for article (PubMed ID: 6201271)
1. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Hanley JA
Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
[TBL] [Abstract][Full Text] [Related]
3. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
Janson ET; Oberg K
Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Rubin J; O'Connell MJ
Cancer Treat Rep; 1986 Dec; 70(12):1459-60. PubMed ID: 3791259
[No Abstract] [Full Text] [Related]
5. [Carcinoid and carcinoid syndrome].
Sukhareva GV; Khomeriki SG
Eksp Klin Gastroenterol; 2008; (3):110-9. PubMed ID: 19145891
[No Abstract] [Full Text] [Related]
6. Effect of melphalan in the malignant carcinoid syndrome.
Lotito CA; Mengel CE
Arch Intern Med; 1969 Jul; 124(1):36-8. PubMed ID: 5791484
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
8. Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.
Janson ET; Kauppinen HL; Oberg K
Acta Oncol; 1993; 32(2):231-3. PubMed ID: 8323762
[TBL] [Abstract][Full Text] [Related]
9. Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG
J Clin Oncol; 1983 Nov; 1(11):727-40. PubMed ID: 6199469
[TBL] [Abstract][Full Text] [Related]
10. [Clinico-biochemical findings in malignant carcinoid during cytostatic therapy (description of a case)].
Vyshinskaia GV; Bassalyk LS; Vasil'ev SA; Gromova NV; Nadezhdina TM
Ter Arkh; 1986; 58(2):129-31. PubMed ID: 3704929
[No Abstract] [Full Text] [Related]
11. [Bronchial carcinoid. Apropos of 5 cases, one of which was a carcinoid syndrome].
Ley R; Vanderhoeft P
Acta Chir Belg; 1969 Apr; 68(4):248-61. PubMed ID: 4324051
[No Abstract] [Full Text] [Related]
12. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
Kvols LK; Moertel CG; O'Connell MJ; Schutt AJ; Rubin J; Hahn RG
N Engl J Med; 1986 Sep; 315(11):663-6. PubMed ID: 2427948
[TBL] [Abstract][Full Text] [Related]
13. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of mitolactol in chemotherapy-refractory metastatic breast cancer.
Creech RH; Catalano RB; Dierks KM; Shah MK
Cancer Treat Rep; 1984 Dec; 68(12):1499-501. PubMed ID: 6548936
[TBL] [Abstract][Full Text] [Related]
15. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
Orlando L; Cardillo A; Rocca A; Balduzzi A; Ghisini R; Peruzzotti G; Goldhirsch A; D'Alessandro C; Cinieri S; Preda L; Colleoni M
Anticancer Drugs; 2006 Sep; 17(8):961-7. PubMed ID: 16940806
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
[TBL] [Abstract][Full Text] [Related]
17. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
[TBL] [Abstract][Full Text] [Related]
18. The carcinoid syndrome: a treatable malignant disease.
Kvols LK
Oncology (Williston Park); 1988 Feb; 2(2):33-41. PubMed ID: 3079320
[TBL] [Abstract][Full Text] [Related]
19. [A case of liver metastases of rectal carcinoid successfully treated with hepatic arterial infusion of methotrexate and 5-fluorouracil].
Takeuchi I; Ishida H; Suzuki T; Nakada H; Tada M; Idezuki Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1929-32. PubMed ID: 10560428
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
Cagayan MS; Gacoba MC
J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]